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Objectives: Staphylococcus epidermidis is a major nosocomial pathogen predominantly associated with
indwelling medical device infections. Studies reportingonS.epidermidisrecovered from hospital personnel in
China are scarce. The aim of this study was to evaluate the carriage and antibiotic resistance of S. epidermidis
among the hospital personnel in Tianjin, China and provide insights into their genetic diversity.
Methods: One hundred and seven S. epidermidis isolates were recovered from 68 hospital personnel in two
public hospitals in Tianjin between March 2018 and May 2018. Staphylococcal cassette chromosome mec
(SCCmec) types were determined by the combination of mec and ccr complexes. Multi-locus sequence
typing was used to determine the sequence types (ST) of S. epidermidis isolates.
Results: Sixty-two (76.5%) isolates were determined to be methicillin-resistant S. epidermidis (MRSE).
Thirty-five(51%) of 68 hospital personnel carried S. epidermidis, of which 32 (91%) werecarriers of MRSE. All
62 MRSE isolates had high levels of resistance to penicillin (90%) and cefoxitin (100%). Thirty-seven (60%)
isolates carried SCCmec type IV, followed by 15 (24%) carrying SCCmec V, and 4 (6%) SCCmec II. Novel STs
were assigned to four S. epidermidis isolates (ST832, ST833, ST834 and ST835).
Conclusions: In this study, the majority of MRSE belonged to cluster II domain of CC2. The ST59-IV was a
dominant clone among isolates recovered from hospital personnel. Determination of new MLST types
confirmed the genetic diversity of these isolates. These observations highlight the need to review the
infection control strategies to reduce the carriage of MRSE among hospital personnel.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial
Chemotherapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Staphylococcus epidermidis is a common colonizer of the human
skin [1], but also one of the major opportunistic pathogens
responsible for medical device associated infections (MDAI).
However, the role of S. epidermidis as a nosocomial pathogen
has been underestimated until late 1980s [2]. Recently, several
studies reported that the distribution of S. epidermidis in human
clinical samples was higher than infections caused by S. aureus in
Greece and India [1,3]. The ever increasing antibiotic resistance* Corresponding author.
E-mail address: h.mkrtchyan@uel.ac.uk (H.V. Mkrtchyan).
http://dx.doi.org/10.1016/j.jgar.2020.02.013
2213-7165/© 2020 The Authors. Published by Elsevier Ltd on behalf of International Societ
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).aggravates the problem, and poses a greater challenge for the
control of hospital acquired infections [4].
Methicillin resistance is mediated by the mecA gene, which
encodes penicillin binding protein 2a that has low affinity to β-
lactam antibiotics, and thus confers methicillin resistance [5]. The
mecA gene is located on a mobile genetic island named
staphylococcal cassette chromosome mec (SCCmec). Up to date
11 SCCmec types have been assigned based on combinations of mec
and ccr complexes [6]. Molecular typing methods, including multi-
locus sequence typing have been instrumental to identify highly
diverse genetic lineages of S. epidermidis [7]. S. epidermidis species
have been assigned onto one major clonal complex (CC2), 8 minor
clonal complexes and 13 singletons [8].
While there are many studies reporting the molecular
epidemiology of S. aureus, studies reporting the moleculary for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-
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documented that hospital personnel are often carriers of
methicillin-resistant staphylococci and aid the dissemination of
hospital-acquired infections [9]. However, little is known about the
genotypic diversity of methicillin-resistant S. epidermidis (MRSE)
among hospital personnel in China. To our knowledge, only two
studies have reported acquisition of MRSE among hospital
personnel with 89% of hospital personnel carrying MRSE in
Sweden [10] and 30% in Shanghai, China [11].
In this study, we evaluate the carriage and susceptibility
patterns of MRSE among the hospital personnel recovered from
two hospitals in Tianjin, China and provide insights into their
genetic diversity.
2. Material and methods
2.1. Study protocol
As a part of a small surveillance study to assess the carriage of
MRSE among the hospital personnel, 107 samples were recovered
from the hospital personnel (n = 68) in two public hospitals in
Tianjin city, North China, between March 2018 and May 2018.
Samples were taken from doctors and nurses’ hands (n = 68) and
nasal cavity (n = 39).
The research protocol and informed consent was approved by
the Ethics committee of Tianjin Science and Technology Commis-
sion (approval No TMUaMEC2017017). All research was performed
in accordance with the relevant guidelines and regulations.
Informed consent was obtained from all participants.
All specimens were inoculated onto mannitol salt agar (MSA,
Oxoid, Basingstoke, UK) and incubated aerobically at 37 C for 24–
48 h.
2.2. Identification
S. epidermidis isolates were subjected to partial 16S ribosomal
RNA (rRNA) gene sequencing using the primers and polymerase
chain reaction (PCR) conditions as described previously [12].
Amplified PCR products were sequenced by Sangon Biotech
(Shanghai, China). Homology searches were carried out using
BLAST tool (NCBI: https://www.ncbi.nlm.nih.gov/) [13].
2.3. Antimicrobial susceptibility test
Susceptibility to 10 antibiotics was tested for all isolates using
standard disk diffusion method. The antibiotics tested included:
CN: gentamicin (10 mg), E: erythromycin (15 mg), FOX: cefoxitin
(30 mg), P: penicillin (10 units), T: tetracycline (30 mg), TEC:
teicoplanin (30 mg), DA: clindamycin (2 mg), CHL: chloramphenicol
(30 mg), LZD: linezolid (30 mg), and RD: rifampin (5 mg). The
isolates were categorized as susceptible, intermediate resistant, or
resistant according to the recommendations of Clinical and
Laboratory Standard Institute (CLSI) [14].
2.4. mecA gene determination and SCCmec typing
The mecA gene was determined for all isolates using PCR
method as described previously [15]. SCCmec types were deter-
mined for all mecA positive isolates by evaluating the mec and ccr
complexes [15].
2.5. Multi-locus sequence typing of S. epidermidis
The mecA positive isolates (n = 60) were analysed for seven
housekeeping genes using MLST as described previously [16]. In
brief, seven house-keeping genes of each isolate were amplified byusing arcC, aroE, gtr, mutS, pyr, tpi, and yqil primers and then
sequenced by Sangon Biotech. The sequence type (ST) for each
isolate was assigned using the S. epidermidis MLST database
(https://pubmlst.org/).
2.6. Statistics
The goeBURST algorithm (http://www.phyloviz.net/goeburst/)
was used to build goeBURST diagram tree [11]. A hierarchy
clustering heatmap was constructed using the MLST data, isolation
source and SCCmec type and resistance profile of the mecA positive
isolates using the r. package Heatmap.plus (https://www.rdocu-
mentation.org/packages/heatmap.plus/versions/1.3/topics/heat-
map.plus.package).Principal component analysis (PCA) was
performed to distinguish between antibiotic resistance profiles
by site using the r packages ‘FactorMineR’ (https://cran.r-project.
org/web/packages/=FactoMineR/index.html) and factoextra
(https://cran.r-project.org/package=factoextra).
The χ2 test was used to determine the quantitative variables. A
P-value <0.05 was considered statistically significant.
3. Results
3.1. Study protocol and identification of isolates
Samples were taken from hands of hospital personnel (n = 68)
and nasal cavity (n = 39). Thirty-five of 68 (51%) hospital personnel
were identified as carriers of S. epidermidis, including 24 of 68 (35%)
carried S. epidermidis on their hands. Nineteen of 39 (49%) hospital
personnel were nasal carriers. In addition, 8 of 68 (12%) carried S.
epidermidis both on their hands and nasal cavity. A total of 165
isolates were recovered from the hands or nasal cavity samples of
the hospital personnel working in two public hospitals in Tianjin
city, China between March 2018 and May 2018. Eighty-one (81/
165; 49%) isolates were identified as S. epidermidis, including 40
isolates recovered from hands and 41 S. epidermidis isolated from
nasal cavity.
3.2. mecA gene determination of S. epidermidis
The mecA gene was determined in 62 (62/81; 76.5%) isolates,
including 30 (30/40; 75%) recovered from hospital personnel
hands, and 32 (32/41; 78%) from nasal cavity. In addition, 33 (33/
68; 49%) hospital personnel were carriers of MRSE, including 19
(19/68; 28%) carried MRSE on their hands and 19 (19/68; 28%)
carried MRSE in their nasal cavity. Moreover, five (5/68; 7%) of the
hospital personnel were carriers of MRSE both on their hands and
in the nasal cavities (Table 1).
3.3. Antimicrobial susceptibility of MRSE
The disc diffusion method was used to test the susceptibility of
all S. epidermidis isolates (n = 81) against 10 antibiotics. Eighty-one
(100%) isolates were resistant to at least one antibiotic. Resistance
to penicillin and cefoxitin was observed in 70 of 81 (86%) and 62 of
81(77%) isolates respectively. Thirty-four (42%) isolates were
resistant to erythromycin (R ≦ 1.3 cm), whereas 18 (26%) isolates
showed intermediate resistance (I = 1.4–2.2 cm) towards
erythromycin. Five (8%) isolates were resistant to gentamicin (R
≦ 1.2 cm), and four (5%) to tetracycline (R ≦ 1.4 cm) (Table 1).
Thirty-one (38%) isolates were resistant to teicoplanin (R ≦ 1.0 cm),
34 (42%) isolates to clindamycin (R ≦ 1.4 cm), 6 (7%) to
chloramphenicol (R ≦ 1.2 cm), 6 (7%) to linezolid (R ≦ 2.0 cm),
and 13 (16%) to rifampin (R ≦ 1.6 cm). All the mecA-negative S.
epidermidis isolates were susceptible to cefoxitin. The majority of
mecA-negative isolates were susceptible to gentamicin,
Table 1
Antibiotic resistance and molecular characterization of mecA gene positive Staphylococcus epidermidis.
ID Hospital Personnel Sites mecA mec ccr SCCmec FOX30 Other antibiotics
CHL30 CN10 DA2 E15 LZD30 P10 RD5 TEC30 T30
1 A A1 H + B 2 IV R S S R S S R S I S
2 A A12 H + B 2 IV R R S I R S R S I S
3 A A2 H + B 2 IV R S S I I S R S R S
4 A A3 H + B 2 IV R S S S S S S S R S
5 A A1 H + B 2 IV R S S I S R R S I S
6 A A1 H + B 2 IV R S S S S S R R R I
7 A A2 H + B 2 IV R S S I S S R S R S
8 A A4 H + B 2 IV R S S S I R R S R S
9 A A12 H + B 2 IV R R S I R S R S I S
10 A A13 H + B 2 IV R S S I R S R S R S
11 A A1 H + B 2 IV R S S I S S R S R S
12 B B2 H + B 2 IV R R R R R R R R R S
13 B B3 H + B 2 IV R R R R I S R S R S
14 B B3 H + B 2 IV R R I I S R R R R S
15 B B4 H + B 2 IV R S S I S S R S I S
16 B B4 H + B 2 IV R S S S S S R S I S
17 B B8 H + B 2 IV R S S I I R R S R I
18 B B11 H + B 2 IV R S S S R S R S I S
19 B B9 H + B 2 IV R S S S S S R S I S
20 B B16 H + B 2 IV R S S S I S R S I S
21 B B18 H + B 2 IV R S R S S S S S I S
22 B B15 H + C 5 V R S S I R S R S I S
23 B B5 H + C 5 V R S S S R S R S R I
24 B B1 H + C 5 V R S S I R S R S R S
25 A A5 H + C 5 V R S S S R S R R I I
26 A A3 H + C 5 V R R S R R S R S R S
27 A A4 H + C 5 V R S S R R S R R I S
28 A A3 H + C 5 V R S S R I S R S I S
29 A A5 H + C 2 C/2 R S I R R S R R I S
30 B B17 H + C 2 C/2 R S S R S S R S I S
31 A A11 NC + A 2 II R S S R R S R S I S
32 A A11 NC + A 2 II R S S R R S R S I S
33 B B19 NC + A 2 II R S S I R S S S I S
34 B B20 NC + A 2 II R S S S R S R S R S
35 A A8 NC + B 2 IV R S S I S S R S R S
36 A A8 NC + B 2 IV R S S R R S R S R S
37 A A12 NC + B 2 IV R S S S R S R S R S
38 A A10 NC + B 2 IV R S S S I S R S I S
39 B B6 NC + B 2 IV R S R S S S R S I S
40 B B7 NC + B 2 IV R S S R S S R S R S
41 A A6 NC + B 2 IV R S S I S R R S I S
42 A A6 NC + B 2 IV R S S R I S R S I S
43 A A10 NC + B 2 IV R S S S I S R S R S
44 B B17 NC + B 2 IV R S S I S S R R I S
45 B B16 NC + B 2 IV R S S I S S R S I S
46 B B12 NC + B 2 IV R S S R S S S S I S
47 B B12 NC + B 2 IV R S S R I S S S S S
48 B B10 NC + B 2 IV R S S R I S R R R S
49 B B16 NC + B 2 IV R S S I S S R S I S
50 B B18 NC + B 2 IV R S S I S S R S R S
51 A A7 NC + C 5 V R S S R I S R S I S
52 A A7 NC + C 5 V R S S I I S R R I S
53 B B13 NC + C 5 V R S S R R S R S R S
54 B B13 NC + C 5 V R S S R R S R R R S
55 B B10 NC + C 5 V R S S R R S R R I R
56 B B10 NC + C 5 V R S S I R S R R I S
57 B B14 NC + C 5 V R S S R I S R S I S
58 B B18 NC + C 5 V R S S I I S R S R S
59 B B1 NC + C 3 C/3 R S R I I S R S I R
60 B B6 NC + C 3 C/3 R S S I S S R S I S
61 B B6 NC + C 3 C/3 R S S S S S R S I S
62 A A9 NC + NT 3 NT R S I I S S S S I S
Penicillin (S  2.9 cm, R  2.8 cm), erythromycin(S  2.3 cm, I = 1.4–2.2 cm, R  1.3 cm), cefoxitin (S  2.5 cm, R  2.4 cm), gentamicin (S  1.5 cm, I = 1.3–1.4 cm, R  1.2 cm),
tetracycline (S  1.9 cm, I = 1.5–1.8 cm, R  1.4 cm), teicoplanin (S  1.4 cm, I = 1.1–1.3 cm, R ≦ 1.0 cm), clindamycin (S  2.1 cm, I = 1.5–2.0 cm, R ≦ 1.4 cm), chloramphenicol (S 
1.8 cm, I = 1.3–1.7 cm, R ≦ 1.2 cm), linezolid (S  2.1 cm, R ≦ 2.0 cm), rifampin (S  2.0 cm, I = 1.7-1.9 cm, R ≦ 1.6 cm).
aMLST type not determined.
A, hospital 1; B, hospital 2; CHL, chloramphenicol; CN, gentamicin; DA, clindamycin; E, erythromycin; FOX, cefoxitin; H, hand; LZD, linezolid; NC, nasal cavity; NT, non-
typeable; P, penicillin; RD, rifampin; T, tetracycline; TEC, teicoplanin.
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Table 2
Antibiotic resistance of mecA gene negative Staphylococcus epidermidis.
ID Hospital Personnel mecA CHL30 CN10 DA2 E15 FOX30 LZD30 P10 RD5 TEC30 T30
63 A A1 - S S R I S S R S R S
64 A A1 – S S I R S S S S R S
65 A A1 – S S R R S S S S I S
66 A A5 – S S R S S S S S I S
67 A A6 – S S R R S S R S I S
68 A A7 – S S R I S S R S I R
69 A A8 – S S R R S S R S I S
70 A A8 – S S R R S S R S I S
71 A A9 – S S I R S S R R R S
72 A A10 – S S I S S S R S I S
73 A A10 – S S I S S S R S R S
74 A A11 – S S R R S S R S I S
75 A A11 – S S R S S S R S I S
76 A A11 – S S R R S S R S I S
77 A A13 – S S S R S S R S I S
78 A A14 – S S R S S S R S R R
79 A A15 – S S I R S S R S R S
80 A A15 – S S R R S S S S I S
81 B B20 – S I R R S S S S I I
Penicillin (S  2.9 cm, R  2.8 cm), erythromycin(S  2.3 cm, I = 1.4–2.2 cm, R  1.4 cm) cefoxitin (S  2.5 cm, R  2.4 cm), gentamicin (S  1.5 cm, I = 1.3–1.4 cm, R  1.2 cm),
tetracycline (S  1.9 cm, I = 1.5–1.8 cm, R  1.4 cm), teicoplanin (S  1.4 cm, I = 1.1–1.3 cm, R ≦ 1.0 cm), clindamycin (S  2.1 cm, I = 1.5–2.0 cm, R ≦ 1.4 cm), chloramphenicol (S 
1.8 cm, I = 1.3–1.7 cm, R ≦ 1.2 cm), linezolid (S  2.1 cm, R ≦ 2.0 cm), rifampin (S  2.0 cm, I = 1.7–1.9 cm, R ≦ 1.6 cm).
A, hospital 1; B, hospital 2; CHL, chloramphenicol; CN, gentamicin; DA, clindamycin; E, erythromycin; FOX, cefoxitin; H, hand; LZD, linezolid; N, nose; NT non-typeable; P,
penicillin; RD, rifampin; T, tetracycline; TEC, teicoplanin.
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mecA-negative isolates were resistant to penicillin, followed by 13
(13/19; 68.4%) to clindamycin, 12 (12/19; 63.2%) to erythromycin,
and 6 (6/19; 31.6%) to teicoplanin (Table 2).
3.4. SCCmec typing of MRSE
SCCmec types were determined for all 62 MRSE isolates. Thirty-
seven (60%) isolates (from hands n = 21; from nasal cavity n = 16)
harboured SCCmec type IV, followed by 15 (24%) SCCmec type V,
and 4 (6%) SCCmec type II. In addition to this, six isolates were non-
typeable, including three (5%) isolates harboured a combination of
class C mec complex and the ccr type 3 complex, and two (3%)
isolates carried class C mec complex and ccr type 2, whereas one
(2%) isolate lacked mec complex but carried ccr type 3 complex
(Table 1).
3.5. Multi-locus sequence typing of MRSE
MLST was performed to determine the STs of 60 MRSE,
including 29 recovered from hospital personnel hands (n = 18)
and 31 from nasal samples (n = 18). The ST59 (n = 19) was the most
common ST, followed by ST35 (n = 4), ST14 (n = 3), ST57 (n = 3),
ST218 (n = 3), ST20 (n = 3), ST49 (n = 2), ST69 (n = 2), ST110 (n = 2),
ST152 (n = 2), ST227 (n = 2), ST466 (n = 2), ST5 (n = 1), ST6 (n = 1),
ST17(n = 1), ST50 (n = 1), ST84 (n = 1), ST130 (n = 1), ST190 (n = 1),
ST192 (n = 1), and ST234 (n = 1). In addition, four isolates contained
novel STs that were assigned as: ST832. ST833, ST834 and ST835.
All 60 MRSE isolates were clustered into clonal complex 2 (CC2) by
the goeBURST algorithm. In addition, no singleton was detected
(Fig. 1).
3.6. Hierarchical clustering and PCA analysis
A hierarchical cluster heatmap was performed on 60 MRSE
isolates based on their site of isolation, SCCmec and MLST types
(Fig. 2A) to their antibiotic resistant profile. These analyses showed
that there was no obvious clustering based on the site of isolation,
SCCmec and MLST types. This was further showed by PCA analysison site isolates as the confidence ellipse overlapped each other
(Fig. 2B).
3.7. Statistical analysis
The χ2 test was used to analyse the quantitative variables. A P-
value <0.05 was considered statistically significant.
4. Discussion
Staphylococcus epidermidis is a major nosocomial pathogen
responsible for device associated infections [1]. Hospital personnel
have an important role of being in direct contact with patients and
subsequently play a key role in cross-transmission of MRSE [9]. In
this study, we report the antimicrobial resistance patterns and
genetic diversity of MRSE among the hospital personnel in Tianjin,
China.
The resistance of MRSE towards penicillin is well documented.
Xin et al [11] reported that 90.4% of S. epidermidis isolates
recovered from hospital environments were resistant to penicillin.
Consistent with their results we have shown that 90% of MRSE
isolates in our study were phenotypically resistant to penicillin. In
addition, we have previously reported high levels of antibiotic
resistance towards penicillin in environmental S. epidermidis (70%)
isolates recovered from London [12]. Interestingly, in this study the
resistance rates towards gentamicin (8%), and erythromycin (35%)
were relatively low compared with others that demonstrated
resistance towards gentamicin and erythromycin as 20% and 50%
respectively [10,11]. Previously, it was shown that cefoxitin disk
diffusion method was preferable for routine methicillin resistance
screening of S. aureus, S. epidermidis and other CoNS isolates [17,18].
In this study, 62 (62/81; 77%) S. epidermidis isolates were resistant
to cefoxitin, all of which carried the mecA gene. Li et al reported
that resistance of clinical S. epidermidis isolates towards penicillin,
cefoxitin, gentamicin and erythromycin were 100%, 100%, 77.8%
and 72.2% respectively [19]. In this study, the resistance towards
non-β-lactam antibiotics in S. epidermidis isolates recovered from
hospital personnel was significantly lower than that of clinical S.
epidermidis isolates, whereas the resistance towards β-lactam
Fig. 1. goeBURST analysis of 60 MRSE isolates recovered from hospital personnel in
China.
ST nodes: dark green circles- sub-group founder; light blue circles- common nodes;
light green- SCCmec II; dark yellow- SCCmec IV; turquoise- SCCmec V; red- SCCmec
C/2; blue- SCCmec C/3; purple- non-typable SCCmec.
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study, 100% S. epidermidis isolates were phenotypically resistant to
at least 1 antibiotic. Twenty-two out of 81 (27%) S. epidermidis
isolates were resistant to 2 antibiotics, 27 isolates (33%) were
resistant to 3 antibiotics, 18 isolates (22%) were resistant to 4Fig. 2. Hierarchy cluster heatmap and PCA analysis of MRSE isolates antibiotic resistance
green tile, sensitive. (B) PCA analysis; 95% confidence ellipse.antibiotics, 5 (6%) isolates were resistant to 5 antibiotics, 5 (6%)
isolates were resistant to 6 antibiotics and 1 (1.2%) isolate was
resistant to 9 antibiotics.
In this study 32 (91%) of 35 S. epidermidis carriers were
identified to carry MRSE. Although, in this study the carriage of
MRSE among the hospital personnel was significantly higher than
among the hospital personnel in Shanghai, China [11], our findings
were consistent with the MRSE rates (89%) among the hospital
personnel in Intensive Care Unit in Sweden [10]. Previously, it was
reported that the rate of MRSE carriage among the volunteers and
in the environment was 11% [20], which was significantly lower
than the rate of MRSE carriage among the hospital personnel.
The size of SCCmec IV and V is smaller than those of SCCmec
types I, II and III, and thus conferring SCCmec IV and V increased
mobility and dissemination ability [21]. Li et al reported that 35% of
clinical MRSE harboured SCCmec types IV and V in China [19]. In
this study, 60% of MRSE harboured SCCmec type IV, followed by
24% harbouring SCCmec type V. We determined that 6% of MRSE
that carried SCCmec type II were recovered from nasal samples.
SCCmec II was reportedly identified in clinical S. aureus, S.
epidermidis and other [19]. Interestingly, we did not identify
SCCmec types I, and III, which in contrast have been identified by
Xin et al in isolates recovered from hospital personnel in Shanghai
[11]. Six previously unclassified SCCmec types were determined in
this study, including three carrying class C mec complex and ccr 3,
and two had a combination of class C mec complex and ccr 2. In
addition, one MRSE was classified as SCCmec 12263 since it lacked
mec complex.
For S. epidermidis,1 major clonal complex (CC2), 8 minor clonal
complexes and 13 singletons have been categorized [16]. In this
study, all MLST types were classified into one major CC2 clonal
complex, hence we did not detect isolates belonging to minor
clonal complexes or singletons (Fig. 1). However, although
belonging to one CC group, in our study, we detected a diversity
of MLST types (n = 25). Miragaia et al. summarized the STs of CC2
that accounted for 74% of the S. epidermidis population, and divided
them into clusters: cluster I: included the predicted ancestor (ST2)
and cluster II: included several subgroup founders (ST5, 6, 57, 85,
and 89) [16]. In this study, the majority of STs were categorized into
cluster II, including those identified as subgroup founders: ST5, 49,
57, 110, 152, and 835 (Fig. 1). In addition, two isolates belonged to
ST35. Miragaia et al. reported that ST2 of cluster I is the most
widely disseminated ST that has been identified in different
countries [16]. In this study, no ST2 was determined among the S.
epidermidis isolates recovered from two hospital personnel in
Tianjin, China. However, the ST59 of cluster II was the most
frequently identified. Isolates belonging to ST59 were reported to
be only the second to the ST2, a prominent cause of clinical
infections in China [11]. Thus, the prevalence of ST59 among the
hospital personnel is rather worrying. profile. (A) Hierarchy clustered heatmap. Red tile, resistant; black tile, intermediate;
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environmental S. epidermidis ST59 isolate carried SCCmec type IV
mobile genetic element [22]. To the best of our knowledge, this is
the first study reporting that isolates belonging to ST59 harboured
unclassified SCCmec types (C/2 and C/3) (Fig. 1).
S. epidermidis ST5 has been associated with clinical and animal
infections [23], whereas S. epidermidis ST6, ST20, ST110, ST130 and
ST152 were associated with clinical infections [8,24,25]. It is largely
known that the main transmission route of staphylococci is person
to person and hospital personnel play a major role in such
transmission [1]. Thus, our study provides further insights on the
colonization of the hospital personnel with S. epidermidis. In
addition, Xin et al. reported a variety of S. epidermidis STs identified
among hospital personnel (ST14, ST16, ST54, ST88, ST153, ST171,
ST184, ST190, ST192, ST193, ST194, ST203, ST204, ST210, ST218,
ST219, ST220, ST226, ST233, ST237, ST262, ST267, ST291, ST327,
ST362, ST387, ST406, and ST466) [11]. Some of the STs (ST14, ST190,
ST218, and ST466) identified in this study were consistent with
their findings. However, in addition to this we also report STs
(ST35, ST57, ST69, ST84, ST227, and ST234) that were not identified
by Xin et al. [11]. In addition, four new MLST types were
determined in this study.
We did not detect any obvious clustering based on site of
isolation, SCCmec types and MLST types (Fig. 2A). This was further
demonstrated by PCA analysis on site isolates as the confidence
ellipse overlapped each other (Fig. 2B). Other authors reported
discrepancies between the antibiotic resistance profile and
different types of SCCmec elements [26]. This report shows that
SCCmec type III and IV in S. epidermidis were more likely to be
resistant to a larger number of antibiotics.
5. Conclusion
The main limitation of this study is that only samples recovered
from the hospital personnel were included. The carriage of MRSE
(91%) was unusually high among hospital personnel who were
carriers of S. epidermidis. We also observed different MRSE
colonization rate in hospital personnel in two hospitals. The
MRSE isolates had high resistance rates towards β-lactam anti-
biotics, but low resistance rates against non-β-lactam antibiotics.
Moreover, the majority of MRSE in this study belonged to cluster II
domain of CC2. ST59-IV was the predominant clone among isolates
recovered from hospital personnel, a ST that was reportedly
associated with clinical infections. Moreover, new MLST types
were determined, thus further confirming the genetic variability of
these isolates. Our data demonstrate that the hospital personnel
may well act as a reservoir of antimicrobial resistance pathogens.
Undoubtedly, there is a need to review the infection control
strategies and implement appropriate screening and monitoring
measures to identify the high carriage of MRSE among hospital
personnel on timely manner.
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